{"a":[{"_":"Inflammation biotech Electra charges up with $350M from upsized IPO","$":{"href":"/biotech/electra-rides-biotech-ipo-surge-charge-350m-upsized-listing","hreflang":"en"}}]}

Summary

Electra Therapeutics completed a Nasdaq IPO listing, raising $350 million, exceeding its original expectations. The inflammation-focused biotech company is part of a biotech IPO surge in 2026.